Androgen Excess Polycystic Ovary Syndrome Society Meeting

点击翻译按钮获取中文摘要

Project Summary/Abstract The meetings of the Androgen Excess-Polycystic Ovary Syndrome (AE-PCOS) Society are the only ones that convene the world's largest group of researchers and clinicians specifically focused on androgen-excess related disorders. Both the Annual and Update meetings bring together diverse participants to discuss their latest research findings, to encourage future research collaborations and to disseminate relevant and accurate health information to the clinical community and general public. The attendees represent several regions of the world and a variety of disciplines including medical, pediatric and reproductive endocrinology, gynecology, internal medicine, psychologists, epidemiologists, clinical nutritionists and physiologists. The two-day Annual Meeting has a well-established format consisting of multiple sessions that include invited scientific lectures, oral and poster presentations, meet-the-professor sessions, all with interactive and/or question and answer opportunities. We provide travel awards for junior investigators and child care awards to encourage the participation of the next generation of researchers and clinicians. The one-day Update Meetings, also held annually, are focused on basic science research and have a specific theme. We have demonstrated participation by females and underrepresented minorities in our meetings, membership and Board of Directors. One of the new highlights is increased collaboration with patient support groups and actively engaging patients and consumers in our meetings. The Society is composed of basic and clinical scientists and clinicians whose major interest is the etiology, diagnosis, and treatment of androgen excess disorders. The AE-PCOS Society has successfully organized 17 Annual Meetings, 4 Update Meetings which are organized as satellite meetings along with the ASRM and Endocrine Society meetings in the USA or stand alone in other international locations. The Society through its meetings and resultant publications (14 guidelines and position statements) has had significant impact on dvelopment of criteria for diagnosis, management and treatment strategies for PCOS.